Dr. Andersen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Bellevue Hospital Center
462 First Ave
New York, NY 10016Phone+1 718-283-6000
Summary
- Dr. John Andersen is a pathologist in Baltimore, MD and is affiliated with multiple hospitals in the area, including Johns Hopkins Hospital and Johns Hopkins Bayview Medical Center. He received his medical degree from Arizona College of Osteopathic Medicine of Midwestern University and has been in practice 8 years. He specializes in anatomic pathology and clinical pathology and is experienced in ovarian cancer pathogenesis..
Education & Training
- Johns Hopkins University School of MedicineFellowship, Gynecological Pathology, 2021 - 2022
- National Capital ConsortiumResidency, Pathology-Anatomic and Clinical, 2013 - 2017
- Arizona College of Osteopathic Medicine of Midwestern UniversityClass of 2013, DO
Certifications & Licensure
- VA State License 2014 - 2026
- NC State License 2019 - 2025
- NY State License 2022 - 2025
- MD State License 2021 - 2022
- American Board of Pathology Pathology - Anatomic/Pathology - Clinical
Publications & Presentations
PubMed
- 92 citationsLeucine-rich alpha-2-glycoprotein-1 is upregulated in sera and tumors of ovarian cancer patientsJohn D. Andersen, Kristin L.M. Boylan, Ronald Jemmerson, Melissa A. Geller, Benjamin S Misemer
Journal of Ovarian Research. 2010-09-10 - 60 citationsIdentification of candidate biomarkers in ovarian cancer serum by depletion of highly abundant proteins and differential in-gel electrophoresisJohn D. Andersen, Kristin L.M. Boylan, Feifei S. Xue, Lorraine B. Anderson, Bruce A. Witthuhn
Electrophoresis. 2010-01-01 - 35 citationsS100A1 expression in ovarian and endometrial endometrioid carcinomas is a prognostic indicator of relapse-free survival.Melissa S. DeRycke, John D. Andersen, Katherine M. Harrington, Stefan E. Pambuccian, Steve E. Kalloger
American Journal of Clinical Pathology. 2009-12-01
Professional Memberships
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: